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Abstract: Exercise produces potential influences on physical and mental capacity in patients with neuropsychiatric disor-
ders, and can be made a viable form of therapy to treat Parkinson’s disease (PD). We report the chronic effects of a regu-
lar physical exercise protocol on cognitive and motor functions, functional capacity, and symptoms in an elderly PD pa-
tient without dementia. The patient participated of a program composed of proprioceptive, aerobic and flexibility exer-
cises, during 1 hour, three days a week, for nine months. Patient used 600 mg of L-DOPA daily, and 1 hour prior to each 
exercise session. Assessment was conducted in three stages, 0-3, 3-6 and 6 to 9 months, using percentual variation to the 
scales Hoehn and Yahr, Mini-Mental State Examination (MMSE), Parkinson Activity Scale (PAS), Beck Depression In-
ventory (BDI), and Unified Parkinson's Disease Rating Scale (UPDRS-III). Reassessment showed clear changes in clini-
cal parameters for Hoehn and Yahr (4 to 2.5), MMSE (14 to 22), PAS (13 to 29), BDI (9 to 7) and UPDRS-III (39 to 27) 
at the end of 9 months. According to our data, exercise seems to be effective in promoting the functional capacity and the 
maintenance of cognitive and motor functions of PD patients. Regular exercise protocols can be implemented as an ad-
junctive treatment for reducing the severity of PD. 
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INTRODUCTION 
Parkinson's disease (PD), a chronic neurodegenerative 
disease, is manifested by a loss of dopaminergic neurons 
from the substantia nigra pars compacta, affecting up to 70% 
of these cells [1]. PD prevalence is around 0.5-1% in people 
aged 65-69 years, increasing to 1-3% among individuals 
aged over 80 years [2]. PD is associated with genetic, envi-
ronmental, and behavioral features, resulting in the main 
symptoms, such as rigidity, postural instability, progressive 
bradykinesia, and tremor. These sensorimotor deficits are 
directly related to falls, reduction in functional independence 
and fatigue experienced by the patients [3].  
Currently available drugs for PD treatment just provide 
relief of symptoms and do not control or prevent the disease 
progression [4]. Although many of these drugs are very 
promising, searching for new alternative treatments is essen-
tial. One such novel therapeutic option is physical exercise. 
Exercise might help by protecting against the disease as well 
as an adjunctive treatment, with proved benefits in terms of  
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maintenance of functional capacity and quality of life [5]. A 
meta-analysis published by Lima et al. [6] showed that 
strength training improved the functional capability of walk-
ing and increased strength. Other meta-analysis found that 
exercise was beneficial for physical function, quality of life, 
strength, balance and gait [7]. According to Falvo et al. [8], 
adaptive changes in neuromuscular functions due to strength 
training are very important because they are specific in PD 
patients, such as musculoskeletal weakness and are associ-
ated with negative changes elapsed by PD. Nevertheless, in a 
recent review [9] evidence in favor of exercise were found, 
however still inconclusive in relation to its efficacy on the 
promotion of quality of life and the reduction of motor and 
cognitive deficits. Additionally, the duration of the protocols 
applied in these studies were mainly shorter than three 
months, which raises questions about the benefits of regular, 
prolonged exercise for PD patients. 
We report the case of a 77-year old female patient, 8 
years with PD and is currently in Hoehn and Yahr [10] stage 
4, without dementia according to criteria established by 
Emre et al. [11]. The patient engaged in a 1-hour exercise 
protocol comprising proprioceptive, flexibility and aerobic 
activities, 3 days per week, for 9 months. She was treated 
with 600 mg L-DOPA on a daily basis, as many before as 
during the 9-month exercise intervention, which at exercise 
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days would be administered 1 hour before the start of the 
training session. Previously to the intervention, a moderate 
cognitive loss was detected by a score 14 in the Mini-Mental 
State Examination (MMSE) [12], as well as a moderate func-
tional capacity, detected by a score 13 in the Parkinson Ac-
tivity Scale (PAS) [13]. A score 39 on the UPDRS III and a 
score of 9 was observed in BDI. Data from the re-
evaluations conducted during the chronic exercise interven-
tion show a clear reduction in the severity of the disease by 
the end of the 9-month period according to percentual varia-
tion (Fig. 1).  
It is well known that PD is associated with a number of 
motor and cognitive deficits [5,9]. Exercise seems to con-
tribute to the protection of the central nervous system (CNS) 
against PD, and can be considered as an adjuvant treatment 
approach to the disease [9]. Also, epidemiological studies 
suggest that exercise reduce the risk for PD [5,9]. Addition-
ally, other studies have been investigating the efficacy of 
exercise on PD, especially in terms of motor performance, 
gait and activities of daily living [9]. Thus, variables such as 
exercise intensity seem to positively modulate the neuropro-
tective effect, since more intense activities would be more 
strongly associated with the induction of neuroprotection [5]. 
These studies showed that exercise is effective in the promo-
tion of the quality of life and in the maintenance of motor 
and cognitive functions [5,9].  
In fact, the enhancement of functional capacity, as con-
sequence of strength [5], proprioceptive and flexibility train-
ing [6], may positively affect patients’ functionality and 
quality of life, which is not necessarily due to neurochemical 
alterations [5]. In terms of cognition, it is known that exer-
cise increases the synthesis and release of various neurotro-
phic factors, such as brain-derived neurotrophic factor 
(BDNF) and insulin-like growth factor (IGF-1), both of them 
are related to healthy cognitive functioning, neurogenesis 
and cerebral plasticity [5,9]. Although there are few studies 
showing that exercise in long term appears to be beneficial 
for PD patients [5,9], our results support the few evidences 
that have been published, especially in terms of cognition. 
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Fig. (1). Percentual variation of disease evolution throughout exercise intervention.  
Note: BDI: Beck Depression Inventory; MMSE: Mini Mental State Examination; PAS: Parkinson Activity Scale; UPDRS: Unified Parkin-
son's Disease Rating Scale.  
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